OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ubiquitin–proteasome system and the role of its inhibitors in cancer therapy
Fatemeh Aziz‐Aliabadi, Beheshteh Sohrabi, Ebrahim Mostafavi, et al.
Open Biology (2021) Vol. 11, Iss. 4
Open Access | Times Cited: 80

Showing 1-25 of 80 citing articles:

Antineoplastic activity of biogenic silver and gold nanoparticles to combat leukemia: Beginning a new era in cancer theragnostic
Ebrahim Mostafavi, Atefeh Zarepour, Hamed Barabadi, et al.
Biotechnology Reports (2022) Vol. 34, pp. e00714-e00714
Open Access | Times Cited: 100

GC-derived exosomal circMAN1A2 promotes cancer progression and suppresses T-cell antitumour immunity by inhibiting FBXW11-mediated SFPQ degradation
Yikai Shen, Jie Lin, Tianlu Jiang, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access | Times Cited: 2

Role of protein degradation systems in colorectal cancer
Zihan Cui, Mingqi Cong, Shengjie Yin, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 13

Metabolic remodeling in cancer and senescence and its therapeutic implications
Yeonju Kim, Yeji Jang, Mi-Sung Kim, et al.
Trends in Endocrinology and Metabolism (2024) Vol. 35, Iss. 8, pp. 732-744
Closed Access | Times Cited: 12

Proteasomal Dysfunction in Cancer: Mechanistic Pathways and Targeted Therapies
Pranit Hemant Bagde, Meenakshi Kandpal, Annu Rani, et al.
Journal of Cellular Biochemistry (2025) Vol. 126, Iss. 1
Closed Access | Times Cited: 1

Role of Ubiquitination-driven Metabolisms in Oncogenesis and Cancer Therapy
Dongqin Yang, Can Yang, Linlin Huang, et al.
Seminars in Cancer Biology (2025)
Closed Access | Times Cited: 1

Oxidative Stress and Redox Imbalance: Common Mechanisms in Cancer Stem Cells and Neurodegenerative Diseases
Nikhil Raj Selvaraj, Durga Nandan, B J Bipin Nair, et al.
Cells (2025) Vol. 14, Iss. 7, pp. 511-511
Open Access | Times Cited: 1

The ubiquitin-proteasome system in the regulation of tumor dormancy and recurrence
Bashar A. Alhasan, А. В. Морозов, Irina V. Guzhova, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 4, pp. 189119-189119
Closed Access | Times Cited: 7

Diagnostic and therapeutic potential of protease inhibition
Natalia Ćwilichowska, K. Świderska, Agnieszka Dobrzyń, et al.
Molecular Aspects of Medicine (2022) Vol. 88, pp. 101144-101144
Closed Access | Times Cited: 26

HSP90β Impedes STUB1‐Induced Ubiquitination of YTHDF2 to Drive Sorafenib Resistance in Hepatocellular Carcinoma
Yuning Liao, Yuan Liu, Cuifu Yu, et al.
Advanced Science (2023) Vol. 10, Iss. 27
Open Access | Times Cited: 16

Role of the ubiquitin–proteasome system on macrophages in the tumor microenvironment
Yue Xiao, Ruiqian Liu, Na Li, et al.
Journal of Cellular Physiology (2024) Vol. 239, Iss. 2
Closed Access | Times Cited: 6

Deaggregation of mutant Plasmodium yoelii de-ubiquitinase UBP1 alters MDR1 localization to confer multidrug resistance
Ruixue Xu, Li-Rong Lin, Zhiwei Jiao, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 6

USP3: Key deubiquitylation enzyme in human diseases
Hongyan Zhang, Wenjing Liu, Yingying Wu, et al.
Cancer Science (2024) Vol. 115, Iss. 7, pp. 2094-2106
Open Access | Times Cited: 5

Once weekly selinexor, carfilzomib and dexamethasone in carfilzomib non-refractory multiple myeloma patients
Cristina Gasparetto, Gary J. Schiller, Sascha A. Tuchman, et al.
British Journal of Cancer (2021) Vol. 126, Iss. 5, pp. 718-725
Open Access | Times Cited: 31

Synergistic antitumor effects of compound-composed optimal formula from Aidi injection on hepatocellular carcinoma and colorectal cancer
Pei An, Lu Dong, Lijun Zhang, et al.
Phytomedicine (2022) Vol. 103, pp. 154231-154231
Closed Access | Times Cited: 19

Sniping Cancer Stem Cells with Nanomaterials
Wen-Da Wang, Yanyu Guo, Zhonglu Yang, et al.
ACS Nano (2023) Vol. 17, Iss. 23, pp. 23262-23298
Closed Access | Times Cited: 12

The roles of protein ubiquitination in tumorigenesis and targeted drug discovery in lung cancer
Zhen Ye, Jingru Yang, Hanming Jiang, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 11

HRD1-induced TMEM2 ubiquitination promotes ER stress-mediated apoptosis through a non-canonical pathway in intestinal ischemia/reperfusion
Xuzi Zhao, Deshun Liu, Yan Zhao, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 2
Open Access | Times Cited: 4

Advances in Proteasome Enhancement by Small Molecules
Dare E. George, Jetze J. Tepe
Biomolecules (2021) Vol. 11, Iss. 12, pp. 1789-1789
Open Access | Times Cited: 27

Role of Polyphenols on Gut Microbiota and the Ubiquitin-Proteasome System in Neurodegenerative Diseases
Hanieh Nargeh, Fatemeh Aziz‐Aliabadi, Marjan Ajami, et al.
Journal of Agricultural and Food Chemistry (2021) Vol. 69, Iss. 22, pp. 6119-6144
Closed Access | Times Cited: 25

Platycodin-D exerts its anti-cancer effect by promoting c-Myc protein ubiquitination and degradation in gastric cancer
Qianqian Xu, Guangzhao Pan, Zhonglan Wang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 10

TCH-165 attenuates cardiac ischaemia/reperfusion injury by balancing mitochondrial dynamics via increasing proteasome activity
Jing Gao, Hui-Xiang Su, Pang‐Bo Li, et al.
European Journal of Pharmacology (2023) Vol. 957, pp. 176011-176011
Closed Access | Times Cited: 10

Role of molecular chaperones and co-chaperones in maintaining proteostasis
Rayees Ahmad Naik, Roshni Rajpoot, Nidhi Gupta, et al.
Elsevier eBooks (2025), pp. 177-251
Closed Access

Page 1 - Next Page

Scroll to top